Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 10, 2021
Continuing to Broaden Eligibility Criteria to Make Clinical Trials More Representative and Inclusive: ASCO-Friends of Cancer Research Joint Research Statement
Edward S Kim, Thomas S Uldrick, Caroline Schenkel, et al.
The Oncologist
|
March 11, 2022
Homologous Recombination Deficiency: Concepts, Definitions, and Assays
Mark D Stewart, Diana Merino Vega, Rebecca C Arend, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 2016
Genome-Wide DNA Methylation Analysis Reveals Epigenetic Dysregulation of MicroRNA-34A in TP53-Associated Cancer Susceptibility
Nardin Samuel, Gavin Wilson, Mathieu Lemire, et al.
The Lancet. Oncology
|
April 20, 2013
Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study
Pedro Castelo-Branco, Sanaa Choufani, Stephen Mack, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 22, 2025
ctDNA Clearance as an Early Indicator of Improved Clinical Outcomes in Advanced NSCLC Treated with TKI: Findings from an Aggregate Analysis of Eight Clinical Trials
Hillary S Andrews, Nevine Zariffa, Katherine K Nishimura, et al.
Acta Neuropathologica
|
October 16, 2014
Alternative lengthening of telomeres is enriched in, and impacts survival of TP53 mutant pediatric malignant brain tumors
Joshua Mangerel, Aryeh Price, Pedro Castelo-Branco, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 3, 2020
Harmonization and Standardization of Panel-Based Tumor Mutational Burden Measurement: Real-World Results and Recommendations of the Quality in Pathology Study
Albrecht Stenzinger, Volker Endris, Jan Budczies, et al.
JCO Precision Oncology
|
August 11, 2022
Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
Diana Merino Vega, Katherine K Nishimura, Névine Zariffa, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 10, 2021
Continuing to Broaden Eligibility Criteria to Make Clinical Trials More Representative and Inclusive: ASCO-Friends of Cancer Research Joint Research Statement
Edward S Kim, Thomas S Uldrick, Caroline Schenkel, et al.
The Oncologist
|
March 11, 2022
Homologous Recombination Deficiency: Concepts, Definitions, and Assays
Mark D Stewart, Diana Merino Vega, Rebecca C Arend, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 2016
Genome-Wide DNA Methylation Analysis Reveals Epigenetic Dysregulation of MicroRNA-34A in TP53-Associated Cancer Susceptibility
Nardin Samuel, Gavin Wilson, Mathieu Lemire, et al.
The Lancet. Oncology
|
April 20, 2013
Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study
Pedro Castelo-Branco, Sanaa Choufani, Stephen Mack, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 22, 2025
ctDNA Clearance as an Early Indicator of Improved Clinical Outcomes in Advanced NSCLC Treated with TKI: Findings from an Aggregate Analysis of Eight Clinical Trials
Hillary S Andrews, Nevine Zariffa, Katherine K Nishimura, et al.
Acta Neuropathologica
|
October 16, 2014
Alternative lengthening of telomeres is enriched in, and impacts survival of TP53 mutant pediatric malignant brain tumors
Joshua Mangerel, Aryeh Price, Pedro Castelo-Branco, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 3, 2020
Harmonization and Standardization of Panel-Based Tumor Mutational Burden Measurement: Real-World Results and Recommendations of the Quality in Pathology Study
Albrecht Stenzinger, Volker Endris, Jan Budczies, et al.
JCO Precision Oncology
|
August 11, 2022
Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
Diana Merino Vega, Katherine K Nishimura, Névine Zariffa, et al.
Page
of 2